基于多学科诊疗的《皮肤基底细胞癌诊疗专家共识(2021)》解读  

Interpretation of Expert Consensus on Diagnosis and Treatment of Cutaneous Basal Cell Carcinoma(2021)by A Multidisciplinary Team

作　　者：王宏兵 王满香[2] 万立 蔡微娜[4] 陈金波[4] 皮国良[5] WANG Hongbing;WANG Manxiang;WAN Li;CAI Weina;CHEN Jinbo;PI Guoliang(Department of Gynecology and Oncology,Hubei Cancer Hospital,Wuhan 430079,China;Department of Pathology,Hubei Cancer Hospital,Wuhan 430079,China;Department of Dermatology,Dermatology Hospital of Southern Medical University,Guangzhou 510091,China;Department of Dermatology,Wuhan No.1 Hospital,Wuhan 430022,China;Center of Radiation Oncology,Hubei Cancer Hospital,Wuhan 430079,China)

机构地区：[1]湖北省肿瘤医院妇瘤科,武汉430079 [2]湖北省肿瘤医院病理科,武汉430079 [3]南方医科大学皮肤病医院皮肤科,广州510091 [4]武汉市第一医院皮肤科,武汉430022 [5]湖北省肿瘤医院放疗中心,武汉430079

出　　处：《肿瘤防治研究》2023年第4期427-432,共6页Cancer Research on Prevention and Treatment

基　　金：2019年度武汉市第七批中青年医学骨干人才培养工程项目(武卫通〔2019〕87号)。

摘　　要：基底细胞癌是最常见的皮肤恶性肿瘤,且发病率呈快速上升趋势,2021年9月,中华医学会皮肤性病学分会皮肤肿瘤研究中心、中国医师协会皮肤科医师分会皮肤肿瘤学组发布《皮肤基底细胞癌诊疗专家共识(2021)》。本共识从基底细胞癌的流行病学、发病机制、临床表现、辅助检查、病理、治疗前评估、治疗、预后及随访宣教多个方面进行了阐述,对促进我国皮肤基底细胞癌患者的规范化诊疗具有重要指导意义。本文将基于多学科诊疗对本共识中重点内容包括临床病理表现、治疗前评估及治疗进展等进行详细解读。Basal cell carcinoma(BCC)is the most common malignant tumor in dermatology with incidence rising rapidly.Expert consensus on diagnosis and treatment of cutaneous basal cell carcinoma(2021)was published in September 2021 by Skin Tumor Research Center,Chinese Society of Dermatology and Subcommittee on Skin Tumor,China Dermatologist Association.This consensus comprehensively describes the epidemiology,pathogenesis,clinical manifestations,auxiliary examination,pathology,pretreatment assessment,treatment,prognosis,and follow-up education.It offers an important guideline for promoting the standardized diagnosis and treatment of skin BCC in China.In this work,multidisciplinary experts interpreted the main contents of the consensus,including clinicopathological findings,pretreatment assessment,and treatment advance.

关 键 词：基底细胞癌 皮肤 多学科诊疗 共识解读 

分 类 号：R739.5[医药卫生—肿瘤]